Skip to main content

Table 3 Differences in serum MMP-2, MMP-9, TIMP-1 and TIMP-2 levels (ng/mL) in the ECD positive/negative patients

From: Relationships between serum HER2 ECD, TIMP-1 and clinical outcomes in Taiwanese breast cancer

 

ECD negative

N = 22

ECD positive

N = 19

ρ valuea

MMP-2

685.09 ± 148.30

753.14 ± 219.17

0.359

MMP-9

39.85 ±29.97

40.82 ± 33.66

0.979

TIMP-1

242.45 ± 102.82

364.88 ± 139.38

0.006

TIMP-2

49.23 ± 21.81

62.92 ± 42.11

0.528

  1. aby Wilcoxon two-sample test.